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A qualitative study to determine physicians’ attitudes toward antibiotic 
prescribing and effectiveness in the treatment of asthma exacerbation 
 
Brent Heineman, BA; Sehar Zulfiqar, MD; Kerry Spitzer, PhD; Mike Moran, BA; Mihaela Stefan, 
MD, PhD, Peter Lindenauer, MD, MSc 
BACKGROUND 
Global Initiative for Asthma guidelines recommend 
antibiotics (AB) for asthma exacerbations only when 
there is strong evidence of lung infection. 
 
Prior studies show: 
• 30-50% of patients with an asthma 
exacerbation receive AB.1 
• AB therapy for asthma exacerbations may be 
associated with a longer hospital stay and 
higher care costs.2 
 
To date, no studies have examined the determinants of 
antibiotic prescribing for asthma exacerbation. 
 
Objective: to assess barriers and facilitators 
to appropriate AB prescribing in asthma 
exacerbations through interviews and focus 
groups with healthcare providers. 
METHODS 
MAPPING INTENTION 
• 16 semi-structured interviews and 2 focus groups 
with hospital-based providers, including ED 
physicians, pulmonologists, hospitalists and 
residents at one teaching hospital and one 
community hospital in New England. 
• The interview instrument was informed by the 
Theoretical Domains Framework (TDF).  
• Interviews and focus groups were audio-recorded 
and transcribed.  
• Coded for themes using NVIVO 12 
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“Yeah, I think there is a bit of everything…I feel like we should be practicing 
under certain evidence-based guidelines. But I feel like if you’ve had more 
experience and you’ve seen more things that you’re kind of doing it based 
on that sometimes.” – EM NP, teaching hospital, 0-5 years in practice 
HOME 
“So [a] potential harm is more resistant bacteria. It is both the case for the 
person and also the general public.” – EM attending, teaching hospital, 0-5 
years in practice 
“I think guidelines are only for residency.” – IM attending, teaching 
hospital, 6-10 years in practice 
“I will basically do whatever we have learned over CMEs…and then we keep having 
updates coming on.  Sometimes we end up having a consult coming on from 
pulmonary.  You always get a teaching from your specialist also, based on the mix 
of things that you see.” – IM attending, teaching hospital, 6-10 years in practice 
 
Experience of individual physician 
 
Clinical inertia? 
Professional Role, Self-efficacy 
“Education works up to a point. But I’ve seen providers who are like, 
‘This is the way I’ve always done it. I don’t care what the literature  
says, this is the way I’m gonna do it.’” – EM attending, teaching 
hospital, 6-10 years in practice 
“I’m a believer as a former resident that residents can really push 
the program and push the practice of attendings.” – EM 
attending, teaching hospital, 0-5 years in practice 
If you are trained in a certain way of doing something, and you’ve been doing it 
for 20, 30 years, it’s very hard to go back, unless you’re someone who is more 
open to the idea of staying well-educated and up-to-date with the resources.” – 
EM resident, teaching hospital 
Individual Provider Characteristics HOME 
“And they might tell you whenever I have this, my 
pulmonologist gives medicine. And I just see them for one 
time there, so I'd rather treat them as they're usually being 
treated.” – IM attending, teaching hospital, 0-5 years in 
practice 
“I have had patients that come in frequently. If they’ve had more than two or four admissions in 
the past year and they keep coming back, I go back and look at if I gave antibiotics, would they 
be not readmitted this time?” – IM attending, community hospital, 0-5 years in practice 
“I don’t wanna miss him getting more sick, and it's coming back to me. So I'm just gonna give this. 
And if someone wouldn’t do any harm, but–and if it needs to do benefit, it'll do the benefit as well.” – 
IM resident, teaching hospital 
 
Reaction to Uncertainty HOME 
“The reason I did not give her – so, again, the other things influenced which I know that she had eczema too, 
I know it was more allergen induced. She had atrophy, she had eczema. In that cases, I will not give 
antibiotics. If she was somebody else, I would probably…” – IM attending, community hospital, 6-10 
years in practice 
“No, I still don’t give 'em antibiotics. I think the -- the best things is gonna be albuterol. 
Mostly albuterol treatments. Sometimes I'll give them magnesium at times. But I -- I never 
give antibiotics to patients.” – IM attending, community hospital, 0-5 years in practice 
“I don’t blame clinicians if they can’t differentiate between COPD or 
early pneumonia and asthma.” – Pulmonologist, teaching 
hospital, 6-10 years in practice 
“Maybe they really have bronchitis or sinusitis, or maybe some touch of pneumonia 
because you know, in chest x-ray, you cannot see all the infiltrate. You seem them only 
on CAT scan and you do not wanna do all those CAT scans.” – IM attending, 
community hospital, 6-10 years in practice 
“Well, we're supposed to give decisions based on what our best medical judgment 
is.” – EM attending, teaching hospital, 16-20 years in practice 
Diagnostic Uncertainty HOME 
Time: “So the question is, is really less of antibiotics or not, it's can 
you afford to wait?” – IM resident, teaching hospital 
Patient Expectation: “Yes, I mean it's just a factor, but usually 
it's a discussion, and I like to think it's shared decision-making.” 
– EM attending, teaching hospital, 6-10 years in practice 
Prescribing Etiquette: “I certainly don’t want to undermine 
that patient relationship.” – IM attending, teaching hospital, 
20+ years in practice 
 
Prescribing Culture: “And in our group, we're very open to 
getting things right. So if there's something we can do better, 
our docs are not kind of those docs that are just gonna say, 
‘No, I'm doing it my way.’” – EM attending, teaching hospital, 
11-15 years in practice 
Environmental Context HOME 
Procalcitonin: “So, there’s two things we don’t use in the ED Procalcitonin and TAG, for two 
reasons. One, is doesn’t change our managements fast enough. Procalcitonin takes too long, 
and then TAG takes too – it’s quick, but we don’t have access to it, so we don’t order those 
tests.” – EM resident, teaching hospital 
Audit and Feedback: “I think it’s really important how you word it exactly, because 
it could be taken as punitive.” – IM resident, teaching hospital 
Pharmacist Review and Call: “I think actually some of the pharmacy directives have 
been helpful in other things. For example, an intravenous antibiotic in hospital. You will 
often get a pharmacist reach out to you and say, look you know, is this indicated?” – IM 
attending, teaching hospital, 0-5 years in practice 
Order Sets: “We’ve relied on order sets a ton. Sometimes they’re a pain to click through and stuff 
like that, I think that’s the number one way we get through things. It makes it accessible and easy.” 
– EM attending, teaching hospital, 0-5 years in practice 
Suggestions HOME 
Physician Education: “I think there are certainly opportunities. I think, [it] might be as simple as 
education. I think that we get much more education on COPD patients than asthma…” – IM 
































































Smoking Cessation Medications Are Infrequently Used  
Among Smokers Undergoing Surgery  
   
Quinn R. Pack MD, MSc, Mihaela S. Stefan MD, PhD; Meng-Shiou Shieh, PhD; Penelope S. Pekow, PhD;  
Steven L. Bernstein MD; Peter K. Lindenauer, MD, MSc.   
  
Institute of Healthcare Delivery and Population Health and University of Massachusetts Medical School at Baystate, Springfield MA; Yale School of Medicine; New Haven CT 
Introduction Results 
Methods 
Hospital Variability in NRT Rates 
 We utilized data from 551 hospitals that participate in the Premier Alliance 
Data Warehouse in 2015-2016.  
 Patients were active smokers  and identified through use of ICD-9 and ICD-
10 codes (ICD-9 CM code 305.1 & ICD-10 codes F17.2x; Z72.0; O99.33X) 
 Patients were hospitalized for a surgical procedure which was expected to 
require length of stay ≥ 2 hospital days, per DRG codes.  
 We used hospital pharmacy charges to measure use of nicotine 
replacement (NRT) including nicotine patch, gum, lozenge, and inhaler.  
 We also evaluated use of varenicline  
 Using a hierarchical generalized logistic regression, we identified factors 
independently associated with use of NRT during hospital days 1 and 2  
 We used the median odds ratio (MOR) to quantify the impact of the hospital 
on a patient’s chance of receiving smoking cessation medications. 
All authors have no conflicts of interest.  Dr. Pack, Dr. Stefan and Dr. Lindenauer were each supported by grants from the  National Heart, Lung and Blood 
Institute of the National Institutes of Health of Bethesda, MD under award numbers 1K23HL135440, HL11463104 and 1K24HL132008 respectively. 
 Among 148,059 smokers, 26,381 (17.8%) received  pharmacologic 
treatment for smoking cessation while hospitalized 
 Median age (IQR) 56 (43 to 65) yrs; 51% female,  74% White; 51% elective 
 The hospital was an important predictor of use of medications. (Figure) 
 The most common therapy was the nicotine patch (17%)  at a median daily 
dose of 21 mg/day.  See Figure. 
Funding and Conflicts of Interest 
Conclusions and Implications 
 The Joint Commission considers inpatient smoking cessation counseling 
and smoking cessation medication prescription as standard of care 
 Little is known about the use of smoking cessation therapies among 
hospitalized smokers undergoing surgical procedures in the  United States 
 
 In this large national sample, we found that fewer than 1 in 5 smokers 
hospitalized for a surgical procedure received any smoking cessation 
medications during their hospitalization 
 Older age, non-white race, elective admission, alcohol abuse, and chronic 
lung disease were associated with less frequent NRT use 
 The strongest predictor of treatment with NRT was the hospital where the 
patient received their care. 
 These findings may be due to differences in hospital policies, physician 
inexperience with prescribing smoking cessation medications, and lingering 
concerns about the impact of NRT on wound healing after surgery 
 This study is limited by lack of information about if patients were offered 
medications and refused them.  
 Use of medications before or after hospitalization is also unknown.   
 Given that hospitalization is usually a teachable moment with high patient 
motivation to quit smoking, there appears to be a large opportunity to 
improve the care of hospitalized patients who undergo surgery 






















Category OR (95% CI) 
Age (tertiles) 18-44 y 1.6 (1.5, 1.7) 
  45-64 y 1.6 (1.5, 1.7) 
  ≥ 65 y Ref. 
Male sex   1.0 (1.0, 1.0) 
Race White Ref.  
  Hispanic 0.6 (0.5, 0.6) 
  Black 0.5 (0.5, 0.6) 
  Other 0.7 (0.6, 0.8) 
Admission Urgency Elective 0.8 (0.7, 0.8) 
Emergent Ref.  
Alcohol abuse   1.7 (1.6, 1.8) 
Chronic Lung Disease 1.5 (1.4, 1.6) 
Drug Abuse 1.4 (1.3, 1.5) 
Psychosis/Depression   1.3 (1.2, 1.3) 
Obesity 0.8 (0.7, 0.8) 
Renal Failure 0.7 (0.7, 0.8) 
Hospital Impact Median Odds Ratio 1.9 (1.8, 2.0) 
Clinical Predictors of Treatment with NRT 
Use and Types of Medications (%) 
Surgical 
 Volume (%) 
Patients with 
NRT (%) OR (95% CI) 
Orthopedic 35.5 23.7 Ref 
Gastrointestinal 23.3 19.8 0.8 (0.7, 0.8) 
Spine 7.6 16.0 0.8 (0.7, 0.8) 
Vascular 7.0 21.3 1.0 (0.8, 1.0) 
Thoracic 5.6 27.6 1.1 (1.0, 1.2) 
Gynecology 4.9 15.1 0.6 (0.5, 0.6) 
Neurosurgery 4.6 20.4 0.9 (0.8, 0.9) 
Obstetrics 4.4 8.9 0.3 (0.3, 0.4) 
Plastics 3.8 30.7 1.1 (1.1, 1.2) 
Urology 2.7 17.8 0.9 (0.8, 0.9) 

























Hospital Rate of NRT Use (%) 
Spirometry Utilization in an Urban Health Center 
Prithwijit Roychowdhury BA, Amulya Amirneni MD, Kevin O’Sullivan BA, Alexander Knee MS, Tara Lagu MD, MPH 
Institute for Healthcare Delivery and Population Science, Baystate Medical Center, Springfield, MA  University of Massachusetts Medical School, Worcester, MA 
  
BACKGROUND 
Asthma, a chronic inflammatory disorder of the airways that is 
characterized by variable airflow obstruction, bronchial 
hyperresponsiveness and underlying inflammation, affects an 
estimated 39.5 million people, including 10.5 million children in 
the United States1.  
An expert panel of clinicians and researchers assembled by the 
National Asthma Education and Prevention Program (NAEPP) has 
recommended that spirometry be performed for all patients in 
whom the diagnosis of asthma is being considered, including 
children >5 years of age3. 
Failure to use spirometry as part of the making an asthma 
diagnosis can lead to either a missed diagnosis or a false diagnosis 
of asthma4, either of which may lead to increases in likelihood of 
ER visits and inappropriate medication prescriptions. Still, 
spirometry is widely underutilized. It has been suggested that, 
compared to high-income and white patients, low-income and 
nonwhite patients are less likely to receive spirometry, even 
though this group has traditionally high rates of health care 
utilization related to asthma5 6. We aim to describe use of 
spirometry in a population where fewer than 50% of the patients 
were white and many were low income. We examined use of 
spirometry both diagnosis and follow up and identified predictors 
of spirometry for this population.    
  
 
 Outcomes  
Our primary outcome was the percentage of patients with asthma 
who received spirometry in their initial diagnosis of asthma as 
well as the percentage of patients with confirmed asthma who 
received spirometry at least once in the follow up management. 
We further examined characteristics of the testing, including use 
of the methacholine challenge. 
METHODS 
DISCUSSION 
Design & Study Population 
We conducted a retrospective cross-sectional/prevalence study of 
adult patients who had a diagnosis of asthma and an appointment 
at High Street Health Center in 2014.  We used the International 
Classification of Diseases (ICD)–Ninth Revision, to identify a range 
of asthma diagnoses. We excluded patients diagnosed with 
neuromuscular conditions and any history of pneumonectomy for 
the sample. 
 
Despite existing guidelines that recommend spirometry use for all 
diagnoses of suspected asthma3 we found that spirometry is 
underutilized in primary care for both the diagnostic evaluation 
and subsequent monitoring of asthma. Among those who did 
receive spirometry, diagnostic tools such as the methacholine 
challenge, were rarely used. The chance of receiving spirometry 
was strongly associated with seeing a specialist: half of those who 
received spirometry saw either a pulmonologist or allergist 
underwent spirometry at any time during the study period; only 
5% of those who did not receive spirometry ever saw a specialist.  
There are potential barriers to routine spirometry utilization such 
as the cost of the machine, lack of time, low renumeration, lack of 
proper training, and limited staff 7.  
Future studies should focus on identifying the specific types of 
barriers that general practitioners in this urban health center face 
in ordering spirometric tests and how these can be addressed.  
 
UMMS-Baystate Research & Education:  Together we advance the state of caring through discovery & innovation 
REFERENCES 
Centers for Disease Control and Prevention. Asthma Facts—CDC’s National Asthma Control Program 
Grantees. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and 
Prevention, 2013.   
Barnett, S. B., & Nurmagambetov, T. A. (2011). Costs of asthma in the United States: 2002-2007. J Allergy Clin 
Immunol, 127(1), 145-152. doi:10.1016/j.jaci.2010.10.020  
 
National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and 
Management of Asthma. (3). (2007). Washington DC National Heart, Lung, and Blood Institute  
 
Joyce, D. P., Chapman, K. R., & Kesten, S. (1996). Prior diagnosis and treatment of patients with normal 
results of methacholine challenge and unexplained respiratory symptoms. Chest, 109(3), 697-701.  
  
Gershon, A. S., Victor, J. C., Guan, J., Aaron, S. D., & To, T. (2012). Pulmonary function testing in the diagnosis 
of asthma: a population study. Chest, 141(5), 1190-1196. doi:10.1378/chest.11-0831 
  
Sokol, K. C., Sharma, G., Lin, Y. L., & Goldblum, R. M. (2015). Choosing wisely: adherence by physicians to 
recommended use of spirometry in the diagnosis and management of adult asthma. Am J Med, 128(5), 502-
508. doi:10.1016/j.amjmed.2014.12.006 
 
Wiener-Ogilvie, S., Huby, G., Pinnock, H., Gillies, J., & Sheikh, A. (2008). Practice organisational 
characteristics can impact on compliance with the BTS/SIGN asthma guideline: Qualitative comparative case 




Spirometry Performed  
Overall No  Yes 











White NH  188 (47.7%) 93 (50.0%) 95 (45.7%) 0.05 
Black NH 43 (10.9%) 19 (10.2%) 24 (11.5%) 
Hispanic 154 (39.1%) 66 (35.5%) 88 (42.3%) 
Insurance 
Private 144 (36.5%) 77 (41.4%) 67 (32.2%) 0.04 
Medicare 84 (21.3%) 33 (17.7%) 51 (24.5%) 




1.7 (0.9) 1.5 (0.8) 1.5 (0.9) <0.001 
Prior Visit with 
Pulmonologist
/Allergist? 
97 (24.6%) 9 (4.8%) 88 (42.3%) 
